*ST新億(600145.SH):實控人及其一致行動人累計增持2.27%股份
格隆匯8月19日丨*ST新億(600145.SH)公佈,自公司實際控制人(及其一致行動人)公吿增持計劃至增持計劃截止日,公司實際控制人(及其一致行動人)萬源匯金、萬盛源累計增持公司股份3384.12萬股,佔公司總股本的2.27%,持有上市公司股份比例從16.51%增加至18.78%,累計增持金額3680.49萬元,完成增持計劃下限的73.61%。
根據增持主體反饋,受疫情及資本市場環境等因素的影響,萬盛源及萬源匯金未能在增持計劃公吿之日起6個月內完成增持計劃,對未能在承諾期限內完成增持給廣大投資者帶來的不便深表歉意。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.